Clinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern Africa
The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Drugs for Neglected Diseases. Recruitment status was Recruiting
Information provided by Drugs for Neglected Diseases